ARCHIVES

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

This article is from The Cancer Letter archive.

Vol. 29 No. | August 12, 2003

Download PDF Visit The Full Archive

Related Articles

MIT Radiation Poisoning Was Deliberate, NRC Investigation Finds

December 15, 1995

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

July 10, 1992

Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal

February 5, 1993

DCCP Board Approves Concept Of NMR Interintuitional Clinical Research

January 27, 1984

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002